SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

A breakout to fresh 52-week highs has drawn attention, with traders citing BRIUMVIs sales growth and the Q3 results and subcutaneous Phase 3 data as key business catalysts. Buyout speculationparticularly involving Sanofiand hopes for short covering are widespread, but no deal is confirmed; some investors argue that execution matters more than takeover chatter.

Crown Castle, Inc. engages in the business of owning, operating, and leasing shared communications infrastructure. It operates through the following segments: Towers, Fiber, and Other. The Towers segment focuses on providing coverage and capacity for wireless carrier network deployments. The Fiber segment includes communications infrastructure offerings of small cells and fiber solutions. The Other segment is involved in corporate assets such as cash and cash equivalents. The company was founded by Ted B. Miller Jr. and Edward C. Hutcheson Jr. in 1994 and is headquartered in Houston, TX.

Crown Castle Inc

Crown Castle International Corp

Reports that SpaceX is discussing access to a large number of U.S. cell sites have focused attention on Crown Castle as traders weigh potential new tower-leasing demand for Starlink Mobile. Bulls see a hybrid satellite-and-terrestrial network as a boost for tower owners, while skeptics note that no agreement is signed and question execution, regulatory approval, and whether speculation has already driven the move.

Algorand (ALGO) is a cryptocurrency launched in 2019. Algorand has a current supply of 10,000,000,000 with 9,075,967,326.643147 in circulation. The last known price of Algorand is 0.09515711 USD and is down -0.23 over the last 24 hours. It is currently trading on 586 active market(s) with $49,581,617.87 traded over the last 24 hours. More information can be found at http://algorand.foundation.

Algorand

ALGO is drawing attention around a contested recovery thesis: bullish traders cite technical support, rebounds and a possible altcoin rotation, while bears point to persistent underperformance and the risk of further declines. Some bulls also highlight Algorands quantum-resistant technology and tokenization or payment use cases, though these are longer-term narratives rather than a confirmed near-term catalyst.

Chainlink (LINK) is a cryptocurrency launched in 2017and operates on the Ethereum platform. Chainlink has a current supply of 1,000,000,000 with 748,099,970.42488396 in circulation. The last known price of Chainlink is 11.67852871 USD and is up 2.18 over the last 24 hours. It is currently trading on 2313 active market(s) with $325,834,414.23 traded over the last 24 hours. More information can be found at https://chain.link/.

ChainLink

A volatile LINK rebound and repeated resistance tests are driving discussion, with bulls pointing to Chainlinks institutional and tokenization integrations, including its role in Coinbases Base tokenized-stock offering and CCIP 2.0. Skeptics warn that rallies have faded before and question whether network adoption will translate into value for the LINK token.

Bitdeer Technologies Group engages in the cryptocurrency mining industry. It generates income through its proprietary mining datacenters. The firm handles complex processes involved in computing such as equipment procurement, transport logistics, datacenter design and construction, equipment management, and daily operations. The company was founded by Wu Jihan in December 2021 and is headquartered in Singapore.

Bitdeer Technologies Group. - Ordinary Shares - Class A

Bitdeer Technologies Holding Co

BTDR is under pressure alongside Bitcoin miners and AI infrastructure stocks as traders cite Bitcoin weakness and a recent downgrade; some also blame short-selling, though that remains speculation. The community is split between calling the selloff an opportunity ahead of earnings and worrying the decline could continue, with many frustrated by BTDRs lagging performance versus peers.

Okta, Inc. engages in the provision of an identity management platform for enterprises. The firm operates through the following geographical segments: United States and International. Its products include single sign-on, multi-factor authentication, access gateway, API access management, authentication, adaptive MFA and lifecycle management. The company was founded by Todd McKinnon and J. Frederic Kerrest in 2009 and is headquartered in San Francisco, CA.

Okta Inc - Ordinary Shares - Class A

Okta Inc

Oktas upcoming addition to the S&P 500 is a major topic, with traders weighing expected index-fund buying against a possible sell-the-news move as the shares weaken. Some posts also cite an alleged DHS-related breach, but those claims are unverified in the discussion.

Northrop Grumman Corp. engages in the provision of advanced aircraft systems. It operates through the following segments: Aeronautics Systems, Defense Systems, Mission Systems, and Space Systems. The Aeronautics Systems segment is involved in the design, development, production, integration, sustainment, and modernization of advanced aircraft systems for the U.S. Air Force, the U.S. Navy, other U.S. government agencies, and international customers. The Defense Systems segment includes integrated battle management systems, weapons systems and aircraft, and mission systems sustainment and modernization. The Mission Systems segment offers advanced mission solutions and multifunction systems, primarily for the U.S. defense and intelligence community, and international customers. The Space Systems segment delivers end-to-end mission solutions through the design, development, integration, production and operation of space, missile defense, launch and strategic missile systems for national security, civil government, commercial, and international customers. The company was founded by John K. Northrop, Thomas V. Jones, and Kent Kresa in 1939 and is headquartered in Falls Church, VA.

Northrop Grumman Corp.

Northrop Grummans strong third-quarter results, higher full-year outlook and record backlog are driving discussion, with traders pointing to sustained defense demand. The reaction is mixed: some see the fundamentals as support for the shares, while others question the rally and expect a pullback.

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

AMGEN Inc.

Amgen is drawing attention after dazodalibep met its Phase 3 endpoint in Sjgrens disease, with traders viewing the result as a pipeline catalyst. The discussion also cites strong IMDELLTRA/Imfinzi small-cell lung cancer data, alongside questions about whether recent momentum is already priced in.

Omeros Corp. operates as a biopharmaceutical company, which engages in the research, discovery, development, and commercialization of small-molecule and protein therapeutics targeting immunologic diseases. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

A newly disclosed performance-based option award for CEO Gregory Demopulos is drawing attention, with traders debating whether its stock-price and service conditions align his incentives with shareholders. The broader discussion remains focused on YARTEMLEAs U.S. sales growth and the next quarterly results, with bullish expectations balanced by caution after the European regulatory rejection.

Helus Pharma, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.

Helus Pharma Inc.

Helus Pharma is drawing attention ahead of expected Q4 topline results from its Phase 3 HLP003 trial for major depressive disorder, a pivotal catalyst for the clinical-stage biotech. Traders are optimistic about the treatments potential as an add-on to existing antidepressants, but debate the binary trial risk, possible dilution and how results could compare with peers.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

IREN Stock Rises: AI Cloud Provider Plans 300MW AI Campus In Spain For 2028

Equity

IREN’s Badajoz campus is set to provide an estimated 300 megawatts of capacity and has already secured grid power for the site as it is built.


IREN's Redbank Campus Adds 900MW To Its Plans, But Power Is Not Secured Yet 

Redbank could lift IREN’s Australian development pipeline to 1.7GW, with construction expected in phases over six to eight years.

Investment Managers Series Trust II - Tradr 2X Long IREN Daily ETF

Bullish Sentiment

<ul class="summary-bullets"><li>IREN shares surged over 4% in premarket trading Wednesday after the AI cloud provider said it plans to offer managed AI cloud services from a planned campus in Badajoz, Spain.</li><li>The company made the announcement during its GTC Berlin conference and also launched IREN Europe.</li><li>Demand for sovereign AI services is growing as European customers grow more concerned about where their data is stored, Co-CEO Daniel Roberts said.</li></ul>IREN shares (IREN) edged higher in early morning trading on Wednesday after the company said it is betting on European companies that want to run their artificial intelligence (AI) closer to home. The AI cloud provider said it plans to offer managed AI cloud services from a planned campus in Badajoz, Spain, with initial operations targeted for 2028.IREN made the announcement at&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/nvidia-gtc-berlin-keynote-jensen-huang-puts-50-billion-price-tag-on-1-gw-ai-factory/cZxt68mRBvI">NVIDIA’s GTC Berlin conference</a>, adding it had set up IREN Europe, a holding company for its business in the region, and had obtained the civil works license for the Spanish site, which the firm originally announced in May.&nbsp;<a href="https://stocktwits.com/symbol/IREN">IREN stock</a> was up over 4% in pre-market trading, erasing its previous-day loss. On Stocktwits, retail sentiment around IREN remained in the ‘extremely bullish’ zone, accompanied by ‘high’ chatter levels over the past day.&nbsp;<figure class="image"><img src="https://news.stocktwits-cdn.com/Screenshot_2026_10_21_at_8_29_45_AM_0f78c3de1b.png" alt="Screenshot 2026-10-21 at 8.29.45 AM.png" width="567" height="325"><figcaption>IREN retail sentiment on October 21 as of 8:57 a.m. ET | Source: Stocktwits</figcaption></figure><h2 class="st-heading-2">IREN Targets Europe’s Sovereign AI Demand&nbsp;</h2>Sovereign AI means local control of data and compute. Customers in Europe care about “where their data sits and who’s running the infrastructure,” said Co-CEO Daniel Roberts.IREN intends to merge the Badajoz capacity with Mirantis' software, which it purchased earlier this year. That includes Mirantis’ k0rdent AI platform, which can deploy and manage AI infrastructure while keeping customer workloads separate, the company said. It also allows customers to choose where data is stored and how it is secured, IREN said. According to an earlier release from the company, IREN announced Aug. 4 that it had closed the deal with Mirantis.<h2 class="st-heading-2">Inside The Badajoz Campus</h2>The campus is expected to have about 300 megawatts (MW) of capacity, IREN said. The company has already secured grid power for the site. It said it continues to hold close discussions with local, regional and national authorities as the project develops.The company stated the site will use closed-loop liquid cooling, which uses very little water. IREN is also making the site compatible to work with NVIDIA’s DSX AI Factory Platform.IREN took ownership of Badajoz through its acquisition of Spanish developer Nostrum Group. The deal closed in June and added about 490MW of secured power in Spain, and its team of more than 60 is led by Gabriel Nebreda, Chief Executive Officer of IREN Spain.<h2 class="st-heading-2">New Leadership In Europe</h2>Former Banco Santander CEO Ángel Corcóstegui will chair the board of IREN Europe, the company said. Roberto Purcaro, previously head of Complex Opportunities globally at Macquarie Capital, has joined the board as Executive Director for the Europe division.&nbsp;Purcaro said “Badajoz is where IREN Europe begins,” adding that “IREN develops its own sites and operates them directly and will do the same in Europe.” He added that “Our focus from here is the campus and the customers who’ll use it.”&nbsp;No customers were identified for Badajoz in the release. The 2028 start date is also still a target subject to permits, grid connections, and financing, IREN said.IREN has been down over 29% so far this year, and lost over 55% in the last 12 months.&nbsp;Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/cryptocurrency/bitcoin-s-bull-score-index-slips-to-60-as-whale-profits-shrink-is-the-rally-losing-steam/cZxt6JQRBv5">Bitcoin's Bull Score Index Slips To 60 As Whale Profits Shrink: Is The Rally Losing Steam?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, a person holds a smartphone displaying the logo of Iren Energy Limited. 

IREN shares (IREN) edged higher in early morning trading on Wednesday after the company said it is betting on European companies that want to run their artificial intelligence (AI) closer to home. The AI cloud provider said it plans to offer managed AI cl

Defiance Daily Target 2X Long IREN ETF

Leverage Shares 2X Long IREN Daily ETF

IREN Limited

Tradr 2X Long IREN Daily ETF

iShares US Technology ETF

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Stocktwits

Stocktwits Polls

$IREX Alright, so you got 500k you’re gonna just slap and forget about it for a while. Time that bottom here…. Love the guesses

Hello there beautiful

$IREX — IREX's recent analyses focused on its significant price decline, technical indicators suggesting oversold conditions, and strategic initiatives including AI tool development and leadership changes.

Feed

News

Sentiment

Fundamentals

Info

IREX Tradr 2X Long IREN Daily ETF

Fundamentals

Latest IREX News